AB
Ambit Biosciences Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Foresite Capital Management I, LLC, was filed 16 Oct 2013.
Ambit Biosciences Corp: what insiders have been doing
This page follows insider dealings at Ambit Biosciences Corp as filed with SEC (Form 4). Ambit Biosciences Corp has had no insider filing for more than a year; the last one goes back to 22 December 2014.
The full history, which starts in 2013, counts 31 purchases against no sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
64
Thresholds
n/a
Buy Volume
€12M
31 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 22 December 2014
Declarations64 total
- 281,624 shares@ US$15.00Common StockSEC:0001104659-14-088135:0
- 307,051 shares@ US$15.00Common StockSEC:0001104659-14-088135:1
- 306,619 shares@ US$15.00Common StockSEC:0001104659-14-088135:2
- 431,527 shares@ US$15.00Common StockSEC:0001104659-14-088135:3
- 69,666 shares@ US$15.00Common StockSEC:0001104659-14-088135:4
- 6,309 shares@ US$15.00Common StockSEC:0001131543-14-000007:0
- 2,362 shares@ US$6.66Common StockSEC:0000950142-14-001811:0
- 36,616 shares@ US$6.7717Common StockSEC:0001181431-13-053974:0Canonical exit: 15 Aug 2013 (T+90)
- 8,120 shares@ US$6.9025Common StockSEC:0001181431-13-053974:1Canonical exit: 18 Aug 2013 (T+90)
- 1,811 shares@ US$6.8362Common StockSEC:0001181431-13-053974:2Canonical exit: 19 Aug 2013 (T+90)
- 5,005 shares@ US$6.7391Common StockSEC:0001181431-13-053974:3Canonical exit: 20 Aug 2013 (T+90)
- 10,000 shares@ US$6.9908Common StockSEC:0001181431-13-053974:4Canonical exit: 1 Sept 2013 (T+90)
- 5,700 shares@ US$7.4532Common StockSEC:0001181431-13-053974:5Canonical exit: 10 Sept 2013 (T+90)
- 7,500 shares@ US$7.4616Common StockSEC:0001181431-13-053974:6Canonical exit: 12 Sept 2013 (T+90)
- 4,817 shares@ US$6.7664Common StockSEC:0001181431-13-053974:7Canonical exit: 22 Sept 2013 (T+90)
- 21,100 shares@ US$6.861Common Stock, $0.001 par value per shareSEC:0001140361-13-022813:0Canonical exit: 20 Aug 2013 (T+90)
- 200 shares@ US$6.861Common Stock, $0.001 par value per shareSEC:0001140361-13-022813:1Canonical exit: 20 Aug 2013 (T+90)
- 12,380 shares@ US$6.9893Common Stock, $0.001 par value per shareSEC:0001140361-13-022813:2Canonical exit: 21 Aug 2013 (T+90)
- 120 shares@ US$6.9893Common Stock, $0.001 par value per shareSEC:0001140361-13-022813:3Canonical exit: 21 Aug 2013 (T+90)
- 21,100 shares@ US$6.86Common Stock, $0.001 par value per shareSEC:0001140361-13-022814:0Canonical exit: 20 Aug 2013 (T+90)
- 200 shares@ US$6.86Common Stock, $0.001 par value per shareSEC:0001140361-13-022814:1Canonical exit: 20 Aug 2013 (T+90)
- 12,380 shares@ US$6.99Common Stock, $0.001 par value per shareSEC:0001140361-13-022814:2Canonical exit: 21 Aug 2013 (T+90)
- 120 shares@ US$6.99Common Stock, $0.001 par value per shareSEC:0001140361-13-022814:3Canonical exit: 21 Aug 2013 (T+90)
- 103,712 shares@ US$0.024Common StockSEC:0001181431-13-030221:0
- 10,500 shares@ US$6.7773Common Stock, $0.001 par value per shareSEC:0001140361-13-022344:0Canonical exit: 18 Aug 2013 (T+90)
25 of 64 declarations
About Ambit Biosciences Corp
Ambit Biosciences Corp is a company focused on developing therapies for cancer treatment. It is listed on NASDAQ under the ticker AMBI.
